Cargando…
Emerging role of PTEN loss in evasion of the immune response to tumours
Mutations in PTEN activate the phosphoinositide 3-kinase (PI3K) signalling network, leading to many of the characteristic phenotypic changes of cancer. However, the primary effects of this gene on oncogenesis through control of the PI3K–AKT–mammalian target of rapamycin (mTOR) pathway might not be t...
Autores principales: | Vidotto, Thiago, Melo, Camila Morais, Castelli, Erick, Koti, Madhuri, dos Reis, Rodolfo Borges, Squire, Jeremy A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283470/ https://www.ncbi.nlm.nih.gov/pubmed/32327707 http://dx.doi.org/10.1038/s41416-020-0834-6 |
Ejemplares similares
-
Pan-cancer genomic analysis shows hemizygous PTEN loss tumors are associated with immune evasion and poor outcome
por: Vidotto, T., et al.
Publicado: (2023) -
The Role of Somatic Mutations on the Immune Response of the Tumor Microenvironment in Prostate Cancer
por: Melo, Camila Morais, et al.
Publicado: (2021) -
Epithelial–Mesenchymal Transition Signaling and Prostate Cancer Stem Cells: Emerging Biomarkers and Opportunities for Precision Therapeutics
por: Chaves, Luiz Paulo, et al.
Publicado: (2021) -
Distinct subtypes of genomic PTEN deletion size influence the landscape of aneuploidy and outcome in prostate cancer
por: Vidotto, Thiago, et al.
Publicado: (2018) -
DNA damage repair gene mutations and their association with tumor immune regulatory gene expression in muscle invasive bladder cancer subtypes
por: Vidotto, Thiago, et al.
Publicado: (2019)